COMMUNIQUÉS West-GlobeNewswire

Oorja Bio Announces Initiation of ORBIT-IPF Phase 2 Clinical Trial Evaluating ORJ-001 for the Treatment of Idiopathic Pulmonary Fibrosis
13/10/2026
Randomized, placebo-controlled study to evaluate the safety, tolerability, and efficacy in a robust, two-part study First-in-class therapeutic targets Alveolar Epithelial Type 2 (AEC2) cells with the aim to halt disease [...]
Spectral AI’s DeepView™ System Showcased at the 2026 American College of Emergency Physicians (ACEP) Scientific Assembly
13/10/2026
DALLAS, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]
SAB BIO Receives FDA Fast Track Designation for SAB-142 in Stage 3 Type 1 Diabetes
13/10/2026
Fast Track designation recognizes the potential of SAB-142 to address an unmet medical need for people with Stage 3 type 1 diabetes MIAMI, Oct. 13, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS ), a [...]
Wave Life Sciences to Present at Chardan’s 10th Annual Healthcare Conference
13/10/2026
CAMBRIDGE, Mass., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, [...]
SS Innovations Submits Response to FDA Request for Additional Information Regarding the Company’s 510(k) Submission for the SSi Mantra
13/10/2026
FORT LAUDERDALE, Fla., Oct. 13, 2026 (GLOBE NEWSWIRE) -- via IBN -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII) , a developer of innovative surgical robotic technologies [...]
DLH Publishes CEO Letter to Shareholders Highlighting “First 100 Days”
13/10/2026
ATLANTA, Oct. 13, 2026 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital, engineering, and scientific solutions for health and defense missions, today [...]
Biodexa announces another Serenta milestone with 100 patients enrolled in its registrational Phase 3 trial in FAP
13/10/2026
October 13, 2026 Biodexa announces another Serenta milestone with 100 patients enrolled in its registrational Phase 3 trial in FAP Update on expected timing of pre-specified futility analysis and database lock Biodexa [...]
Prelude Announces Clinical Trial Collaboration and Supply Agreement with Lilly to Evaluate KAT6A Selective Degrader PRT13722 in Combination with Verzenio® and Inluriyo® in Patients with HR+/HER2- Breast Cancer
13/10/2026
Combination cohorts are part of Prelude’s Phase 1 trial evaluating PRT13722 in patients with HR+/HER2- breast cancer, on track to initiate enrollment in the fourth quarter of 2026 The collaboration is underpinned by pre [...]
Ever After Foods and Roslin Technologies Achieve Major Leap in Cultivated Meat Productivity
13/10/2026
Collaboration Demonstrates Substantially Higher Protein and Biomanufacturing Productivity While Producing Structured Cultivated Tissue HAIFA, Israel and EDINBURGH, Scotland, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Ever After [...]
Aclarion to Present at the 20th Annual LD Micro Main Event
13/10/2026
BROOMFIELD, Colo., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Aclarion (NASDAQ: ACON) announced today that it will participate in the 20th Annual LD Micro Main Event, taking place October 19-21, 2026 at the Luxe Sunset Boulevard [...]
5 Questions People Ask When Every Weight Loss Approach Has Failed
13/10/2026
Trilivy's™ mission is lifelong transformation through metabolic science and human connection Baltimore, MD, Oct. 13, 2026 (GLOBE NEWSWIRE) -- When every weight loss approach has failed , individuals wonder what went [...]
VERAXA Biotech Presents in vivo Proof-of-Concept Data for BiTAC®-ADC Technology at World ADC Congress
13/10/2026
In vivo data confirm activation of prodrug payload inside tumor cells following systemic administration of BiTAC-ADC molecules leading to potent anti-tumor activity ZURICH, SWITZERLAND – October 13, 2026 -- VERAXA [...]
ZoomRx Launches Marketing Asset Testing (MAT) on Sagan Agents, Bringing Continuous, Channel-Specific Asset Testing to Pharma Brand Teams
13/10/2026
A new AI-powered application replaces the yearly messaging or concept testing study with cost-effective, iterative tests that optimize every marketing asset using synthetic and real HCPs, delivering results in days [...]
Entera Presents Markedly Enhanced Anabolic Effects of EB613 (First-in-Class Oral PTH(1-34) Tablet) in Postmenopausal Women with Osteoporosis at High Risk of Fracture and Showcases Phase 3 Design at ASBMR 2026 Annual Meeting
13/10/2026
Post-hoc Phase 2 data show greater bone mineral density (BMD) gains and anabolic effect with EB613 in postmenopausal women with baseline T-scores of ≤-2.5 (osteoporosis) versus T-scores of >-2.5 (osteopenia) These [...]
Visara Expands Ophthalmology Pipeline with Exclusive License for Investigational Nerve Growth Factor Therapy for Neurotrophic Keratitis
13/10/2026
Visara secures exclusive worldwide rights, excluding Greater China, from Wuhan Hiteck Biological Pharma to develop and commercialize HT006.2.2 Visara plans to develop HT006.2.2 as VIS-102, its second clinical-stage [...]
Opus Genetics to Present at the Chardan Annual Healthcare Conference
13/10/2026
RESEARCH TRIANGLE PARK, N.C., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore [...]
Sironax Advances Enrollment in Phase 2 FORGE-LM Obesity Trial of NAMPT Activator SIR4156
13/10/2026
Evaluating first-in-class asset to potentially address current obesity treatment deficiencies by promoting weight loss and preserving lean body mass WALTHAM, Mass., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Sironax, a global [...]
SCIENTURE Reports Approximately $1.22 Million in Unaudited Preliminary Q3 2026 Revenue, Achieving 256% Sequential Growth
13/10/2026
Continued Arbli ™ sales growth, combined with REZENOPY ™ commercial launch in August 2026 and initial wholesale shipments, drives significant sequential revenue growth Arbli ™ wholesale unit sales increased 74% [...]
The Mindful CRNA Bootcamp Trains Nurses to Handle the Pressure of CRNA School
13/10/2026
Starting October 21, the live program helps nurses build the inner capacity that CRNA school demands. Founder Amanda Kay, MSN, CRNA, will close it with news about the platform's next chapter. CHICAGO, Oct. 13, 2026 ( [...]

Pages